Utilización del ensayo del ácido 2-tiobarbitúrico (ATB) para evaluar el proceso autooxidativo en alimentos

In this overview several aspects concerning the application of 2-thiobarbituric acid (TBA) test for measuring oxidative rancidity in foods are described and discussed. Different factors like food processing, sample induced oxidation and preparation, applied methodologies and interferences, are considered. The application of the TBA test to some foods like meats, fish, eggs, milk and dairy products, cereals, infant-foods, animal fats and vegetable oils are described. Correlation between TBA index or TBA number and other oxidation indices (i.e. peroxide value) as well as sensory evaluation are also considered.<br><br>En esta revisión científica se recogen diferentes aspectos de la aplicación del ensayo del ácido 2-tiobarbitúrico (ATB) a la medida del grado de autooxidación de alimentos lipídicos. Se consideran las diferentes formas de procesado del alimento, de inducción voluntaria a la autooxidación, de preparación de las muestras, técnicas empleadas y posibles interferencias. Se contempla el estudio y aplicación del método a muestras de carne, pescados, huevos, leche y derivados lácteos, cereales, productos dietéticos infantiles, grasas animales y aceites vegetales comestibles. Se hace referencia a la posible correlación con otros índices de oxidación ya establecidos, como el índice de peróxidos y otros, así como también la posible correlación favorable entre los valores del índice o número de ATB y la evaluación sensorial del proceso autooxidativo (grado o estado de rancidez)

The utility of Next Generation Sequencing for molecular diagnostics in Rett syndrome

Rett syndrome (RTT) is an early-onset neurodevelopmental disorder that almost exclusively affects girls and is totally disabling. Three genes have been identified that cause RTT: MECP2, CDKL5 and FOXG1. However, the etiology of some of RTT patients still remains unknown. Recently, next generation sequencing (NGS) has promoted genetic diagnoses because of the quickness and affordability of the method. To evaluate the usefulness of NGS in genetic diagnosis, we present the genetic study of RTT-like patients using different techniques based on this technology. We studied 1577 patients with RTT-like clinical diagnoses and reviewed patients who were previously studied and thought to have RTT genes by Sanger sequencing. Genetically, 477 of 1577 patients with a RTT-like suspicion have been diagnosed. Positive results were found in 30% by Sanger sequencing, 23% with a custom panel, 24% with a commercial panel and 32% with whole exome sequencing. A genetic study using NGS allows the study of a larger number of genes associated with RTT-like symptoms simultaneously, providing genetic study of a wider group of patients as well as significantly reducing the response time and cost of the study